SCHEMBL8769887

SCHEMBL8769887

O=C(N/N=C/c1cccc(/C=N/NC(=O)c2ccc(N3CCNCC3)cc2)c1)c1ccc(N2CCNCC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.56
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 2/20 0.56
MAPT P10636 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
CA2 P00918 8/20 0.54
CA9 Q16790 8/20 0.54
CA7 P43166 5/20 0.54
DUSP3 P51452 1/20 0.53
PTPN5 P54829 1/20 0.53
PTPN11 Q06124 1/20 0.53
TDP1 Q9NUW8 2/20 0.53
PLEC Q15149 1/20 0.53
CTDSP1 Q9GZU7 1/20 0.53
CA1 P00915 6/20 0.53
CA12 O43570 3/20 0.53
KDR P35968 1/20 0.52
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8769257 0.89 CA2 (0.65) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL8768854 0.86 ALDH1A1 (0.74) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL8769050 0.78 POLB (0.72) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL8771985 0.76 POLB (0.86) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL8767795 0.75 HDAC3 (0.72) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL8768019 0.75 ALDH1A1 (0.71) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL13569015 0.74 TDP1 (0.65) POLBKDM4EMAPTMEN1KMT2A
SCHEMBL13568922 0.74 POLB (0.64) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL10061533 0.73 CA2 (0.72) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL8771684 0.73 RAB9A (0.85) POLBALDH1A1KDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9622991-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2017-04-18 US disclosed
US-9144557-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2015-09-29 US disclosed
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2015-09-10 US disclosed
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2012-11-22 US disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF POLB 3224/4885ALDH1A1 2736/4885KDM4E 1944/4885
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF POLB 3224/4885ALDH1A1 2736/4885KDM4E 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.